Results 21 to 30 of about 2,084 (139)

Recent Total Syntheses of Cephalotaxine‐Type Alkaloids and Their Structural Diversification (2021–2024): An Update

open access: yesAsian Journal of Organic Chemistry, Volume 14, Issue 3, March 2025.
This review presents an analysis of ten recent total syntheses of cephalotaxine‐type alkaloids published between 2021 and 2024. The structural diversification strategies developed during this period are described. Additionally, a new structural classification system for this alkaloid class is proposed.
Yeju Oh, Anagha Reneesh, Hongjun Jeon
wiley   +1 more source

Stereocontrolled addition of Grignard reagents to oxa-bridged benzazepines: highly efficient synthesis of functionalized benzazepine scaffolds

open access: yesRSC Advances, 2020
An efficient and highly diastereoselective synthesis of 2-substituted benzo[b]azepin-5-olviastereocontrolled addition of Grignard reagents to oxa-bridged benzazepines has been developed.
Yuewei Zhang   +4 more
openaire   +3 more sources

Phenol (bio)isosteres in drug design and development

open access: yesArchiv der Pharmazie, Volume 358, Issue 1, January 2025.
This review explores the pivotal role of phenol bioisosteres in drug design, highlighting their potential to overcome the limitations of phenolic compounds, such as poor bioavailability and rapid metabolism. By examining diverse bioisosteric replacements, from benzimidazolones to quinolinones, it is demonstrated how these modifications enhance drug ...
Calvin Dunker   +2 more
wiley   +1 more source

Optimized psilocybin production in tryptophan catabolism‐repressed fungi

open access: yesMicrobial Biotechnology, Volume 17, Issue 11, November 2024.
Here, we developed an in vivo psilocybin production chassis, based on repression of l‐tryptophan catabolism. By genome mining, we identified two aminotransferase ARO8/9 orthologs in Aspergillus nidulans involved in l‐tryptophan catabolism. Double deletion of the aminotransferase genes aroH1 and aroH2 resulted in a 10‐fold increased psilocybin ...
Slavica Janevska   +12 more
wiley   +1 more source

Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review

open access: yesChemMedChem, Volume 19, Issue 9, May 2, 2024.
Searching for a cure for neuroblastoma: This review highlights the urgent need to find a cure for high‐risk neuroblastoma. It provides an overview of the current treatment available and the drug discovery approach of seven drugs that reached clinical trial.
A. Gerges, U. Canning
wiley   +1 more source

Shedding Light on the D1‐Like Receptors: A Fluorescence‐Based Toolbox for Visualization of the D1 and D5 Receptors**

open access: yesChemBioChem, Volume 25, Issue 2, January 15, 2024.
We herein report the identification of UR‐NR435 (25), a SCH‐23390‐based fluorescent ligand bearing a 5‐TAMRA dye, as suitable for fluorescence microscopy at the D1R. Single‐digit nanomolar binding affinity could be determined in radioligand competition binding and molecular brightness studies at D1‐like receptors.
Niklas Rosier   +11 more
wiley   +1 more source

Palladium-Catalyzed [5 + 2] Rollover Annulation of 1-Benzylpyrazoles with Alkynes: A Direct Entry to Tricyclic 2-Benzazepines. [PDF]

open access: yesOrg Lett, 2023
Suárez-Lustres A   +4 more
europepmc   +1 more source

Asymmetric synthesis of trans-3,4-disubstituted tetrahydro-2-benzazepines

open access: yesARKIVOC, 2010
David Dumoulin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy